Cargando…
NO EXCESS MORTALITY ASSOCIATED WITH CONCOMITANT ACE INHIBITOR OR ARB USE IN HOSPITALIZED PATIENTS WITH COVID-19
Autores principales: | Annie, Frank H., Bates, Mark, Embrey, Sarah, Alkhouli, Mohamad, Bhatt, Deepak, Misenheimer, Jacob, George, Hannah, Gwinn, Ronald, Nanjundappa, Aravinda |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Cardiology Foundation. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091226/ http://dx.doi.org/10.1016/S0735-1097(21)04431-4 |
Ejemplares similares
-
THE EFFECT OF A TISSUE PLASMINOGEN ACTIVATOR ON MYOCARDIAL INFARCTION THAT ARE POSITIVE FOR COVID-19
por: Annie, Frank H., et al.
Publicado: (2021) -
THE EFFECT OF COVID-19 ON CARDIOVASCULAR PRODUCERS
por: Annie, Frank H., et al.
Publicado: (2021) -
ASSOCIATION BETWEEN MYOCARDITIS AND MORTALITY IN COVID-19 PATIENTS IN A LARGE REGISTRY
por: Annie, Frank H., et al.
Publicado: (2021) -
ASSOCIATION BETWEEN IN-HOSPITAL MORTALITY AND ACE/ARB INHIBITOR USAGE
por: Ruge, Max, et al.
Publicado: (2022) -
ACE-I AND ARBS DO NOT INFLUENCE THE CHEST CT PRESENTATION AND 1-YEAR SURVIVAL OF COVID-19 PATIENTS: ITALIAN MULTICENTER REGISTRY
por: Birtolo, Lucia Ilaria, et al.
Publicado: (2022)